MBNL1 and myotonic dystrophy type 1: In terms of the blocking strategy, studies have shown that short locked nucleic acids (all-LNAs) complementary to CUG repeats can effectively reduce RNA foci in DM1 cell cultures and animal models, and efficiently and specifically correct MBNL1-sensitive splicing defects (162).